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This study aimed to test for overlap in genetic influences between psychotic-like experience traits
shown by adolescents in the community, and clinically-recognized psychiatric disorders in adult-
hood, specifically schizophrenia, bipolar disorder, and major depression. The full spectra of
psychotic-like experience domains, both in terms of their severity and type (positive, cognitive, and
negative), were assessed using self- and parent-ratings in three European community samples aged
15–19 years (Final N incl. siblings56,297–10,098). A mega-genome-wide association study
(mega-GWAS) for each psychotic-like experience domain was performed. Single nucleotide poly-
morphism (SNP)-heritability of each psychotic-like experience domain was estimated using
genomic-relatedness-based restricted maximum-likelihood (GREML) and linkage disequilibrium-
(LD-) score regression. Genetic overlap between specific psychotic-like experience domains and
schizophrenia, bipolar disorder, and major depression was assessed using polygenic risk score
(PRS) and LD-score regression. GREML returned SNP-heritability estimates of 3–9% for psychotic-
like experience trait domains, with higher estimates for less skewed traits (Anhedonia, Cognitive
Disorganization) than for more skewed traits (Paranoia and Hallucinations, Parent-rated Negative
Symptoms). Mega-GWAS analysis identified one genome-wide significant association for Anhedo-
nia within IDO2 but which did not replicate in an independent sample. PRS analysis revealed that
the schizophrenia PRS significantly predicted all adolescent psychotic-like experience trait domains
(Paranoia and Hallucinations only in non-zero scorers). The major depression PRS significantly pre-
dicted Anhedonia and Parent-rated Negative Symptoms in adolescence. Psychotic-like experiences
during adolescence in the community show additive genetic effects and partly share genetic influ-
ences with clinically-recognized psychiatric disorders, specifically schizophrenia and major
depression.
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1 | INTRODUCTION
Psychotic-like experiences, also referred to as psychotic experiences,
are traits in the community that at the extreme resemble symptoms of
psychotic disorders, such as schizophrenia. Based on principal
component analyses, psychotic-like experiences can be separated into
replicable and specific domains, such as positive, cognitive, and nega-
tive domains (Ronald et al., 2014; Wigman et al., 2012). Psychotic-like
experiences are common in the general population, particularly during
adolescence (Freeman, 2006; Ronald et al., 2014). Evidence suggests
that psychotic-like experiences are dimensional: they show varying
degrees of severity and taxometric analyses support their continuous
nature in adolescence (Ahmed, Buckley, & Mabe, 2012; Daneluzzo
et al., 2009; Taylor, Freeman, & Ronald, 2016). Adolescence is just prior
to a peak time of onset for several psychiatric disorders, particularly
schizophrenia, bipolar disorder, and major depression (Laursen, Munk-
Olsen, Nordentoft, & Mortensen, 2007). Psychotic-like experiences
predict many types of psychiatric disorders and suicidal ideation with
significant odds ratios of 1.3–5.6 (Cederl€of et al., 2016; Fisher et al.,
2013; Kelleher et al., 2012, 2014; McGrath et al., 2016; Werbeloff
et al., 2012; Zammit et al., 2013).
Twin studies report modest heritability of psychotic-like experience
domains with typically between a third and a half of the variance
explained by genetic influences (Ericson, Tuvblad, Raine, Young-Wolff, &
Baker, 2011; Hay et al., 2001; Hur, Cherny, & Sham, 2012; Linney et al.,
2003; Polanczyk et al., 2010; Wigman et al., 2011; Zavos et al., 2014).
One study to date has reported single nucleotide polymorphism (SNP)-
heritability estimates ranging from 0 to 32%. These results suggest that
common genetic variation plays a role in at least some types of adolescent
psychotic-like experiences (Sieradzka et al., 2015), but larger studies are
needed to offer accurate estimates.
The one previous genome-wide association study (GWAS) of
adolescent psychotic-like experiences assigned 3,483 individuals to
high- or low-scoring groups based on a measure of positive psychotic-
like experiences that combined paranoia, hallucinations, and delusions
(Zammit et al., 2014). No locus achieved genome-wide significance.
The Psychiatric Genomics Consortium 2 schizophrenia GWAS has
been previously used twice to test for an association between genetic
risk of schizophrenia and adolescent psychotic-like experiences (these fol-
lowed one study using Psychiatric Genomics Consortium 1 schizophrenia
GWAS results; Zammit et al., 2014). The first of these studies used quan-
titative measures of individual psychotic-like experiences in adolescence
in a sample of N52,133–2,140 and reported no significant positive asso-
ciation between any of the psychotic-like experience domains and schiz-
ophrenia genetic risk (Sieradzka et al., 2014). This study also reported no
significant positive association with bipolar disorder genetic risk. A sec-
ond study with N53,676–5,444 tested for an association between
schizophrenia genetic risk and dichotomous outcomes on several scales:
a combined positive psychotic-like experiences scale (which included par-
anoia, hallucinations, delusions, and thought interference), a negative
symptoms scale, a depressive disorder scale, and an anxiety disorder scale
(Jones et al., 2016). This second study reported a significant positive
association between schizophrenia genetic risk and both high negative
symptoms and high anxiety disorder. There was no association with the
positive psychotic-like experiences or depressive disorder scales.
Schizotypal traits are closely related to psychotic-like experiences.
Schizotypal traits focus on differences in personality that reflect liability
to psychotic disorders rather than the presentation of subclinical
psychotic-like experiences. Previous twin studies of schizotypal traits
report modest heritability (Ericson et al., 2011; Lin et al., 2007), and
studies are starting to explore the link between polygenic risk for
schizophrenia and schizotypal traits (Hatzimanolis et al., 2017). In light
of the differences in the constructs of schizotypy and psychotic-like
experiences, we focused our brief review on psychotic-like experiences.
Our study aimed to test for overlap in genetic influences between
specific psychotic-like experience domains in adolescence and
psychiatric disorders—specifically, schizophrenia, bipolar disorder, and
major depression. Four psychotic-like experience subscales were used,
derived from principal component analysis: Paranoia and Hallucina-
tions, Cognitive Disorganization, Anhedonia, and Parent-rated Negative
Symptoms. We also present the largest GWAS to date of adolescent
psychotic-like experiences using a community sample of 6,297–10,098
individuals (including siblings) from three European studies. As such our
study also aimed to identify novel common genetic variants associated
with specific psychotic-like experience domains and to estimate their
SNP-heritability.
2 | MATERIALS AND METHODS
2.1 | Samples
Three European general population samples of comparable ages were
included: Twins Early Development Study (TEDS) (Haworth, Davis, &
Plomin, 2013) a community sample born in England and Wales (mean
age 16.32 years); Avon Longitudinal Study of Parents and Children
(ALSPAC) (Boyd et al., 2012) a cohort from the United Kingdom (mean
age 16.76 years); Child and Adolescent Twin Study in Sweden (CATSS;
Anckarsäter et al., 2011) a twin cohort in Sweden (mean age 18.31
years). Sample descriptions and ethical consent information are
available in Supporting Information Note S1. Standard exclusion criteria
for GWASs of behavioral and cognitive traits were used (Supporting
Information Table S1) (Docherty et al., 2010).
2.2 | Measures
We established comparable quantitative scales of psychotic-like experi-
ence domains across samples. The subscales in the Specific Psychotic
Experiences Questionnaire, used in TEDS, were the starting point
(Ronald et al., 2014). The other two samples had used similar
self-report items that were mapped onto domains of paranoia, halluci-
nations, cognitive disorganization, anhedonia, and parent-rated negative
symptoms. The original measures available within each sample are listed
in Supporting Information Note S2. The content of each psychotic-like
experience domain used within each sample is given in Supporting
Information Tables S2–S5. Cronbach’s alphas (measure of reliability) of
each scale within each sample are listed in Table 1.
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2.3 | Phenotypic harmonization
Items were inspected to allow for harmonization of psychotic-like
experience domains across samples via a two-stage process. First, two
expert clinicians (AC and DF) matched items across samples that were
capturing the same underlying construct (to ensure construct and con-
tent validity) based on their clinical knowledge and experience with
psychotic-like experience measures. Second, the matched items within
each sample were analyzed via principal components analysis, a
psychometric approach used to determine individual components
underlying the items. This process was used to identify the presence of
distinct psychotic-like experience domains.
Individuals with >50% missingness for any psychotic-like experi-
ence domain were excluded from all analyses. The remaining missing
phenotypic data was imputed using multiple imputation in R (Buuren
& Groothuis-Oudshoorn, 2011). Imputation of item level data was
carried out separately for each sample and psychotic-like experience
domain. Individual scores of the resulting psychotic-like experience
subscales were calculated using sum scores. To ensure the equal
contribution of each item to the sum score, item response values
were rescaled to values between 0 and 1. The phenotypic correla-
tions between specific psychotic-like experiences within each sample
and in all samples combined are in Supporting Information Table S6.
Sum scores for each psychotic-like experience subscale were normal-
ized using inverse rank-based normalization (data ties ranked ran-
domly) and then standardized. The median correlation between a
given scale before and after normalization was 0.92 (Supporting
Information Table S7), dependent on skew of the original scale. The
normalized scores were then regressed against the following covari-
ates: sex, age, age2, sex*age, sex*age2, study, and the top 8 principal
components of ancestry. Principal components of ancestry were
jointly calculated across all three samples using PLINK1.9 (https://
www.cog-genomics.org/plink2) (Chang et al., 2015) based only on
observed genetic variation.
2.4 | Genotype imputation and quality control
procedure
Genotypic data from each sample was imputed using the 1KG Phase 3
v5 to maximize genome-wide overlap between samples. After imputa-
tion, stringent variant and individual level quality control thresholds
were applied in all samples before converting to hard-call genotypes
(certainty threshold50.9) and merging the three data sets for com-
bined analysis. For further information see Supporting Information
Note S3. Information on DNA collection and genotyping is given in
Supporting Information Note S4.
2.5 | Estimation of SNP-heritability
SNP-heritability estimates were calculated within each sample and
then meta-analyzed to provide meta-SNP-heritability estimates. The
meta-analysis of SNP-heritability estimates approach was taken to
avoid a downward bias due to possible genetic heterogeneity
between samples. Inverse variance weighted meta-analysis was used.
Secondary analysis of mega-SNP-heritability, estimated across samples
simultaneously, was also performed to estimate the proportion of
phenotypic variance that could be explained by the mean genetic
effects across samples.
Two methods were used to estimate SNP-heritability: genomic-
relatedness-matrix restricted maximum-likelihood (GREML) in genome-
wide complex trait analysis (GCTA), and linkage disequilibrium (LD)-
score regression. Related individuals were included in both meta- and
mega-GREML analyses (Zaitlen et al., 2013). LD-score regression
(Bulik-Sullivan et al., 2015) was also performed within (meta-) and
TABLE 1 Descriptive statistics for psychotic-like experience domains in each sample
Specific PE la rb Range Skew ac Nd N sibse
TEDS
Paranoia and hallucinations 0.43 0.51 0–3.90 2.03 0.73 2,994 827
Anhedonia 3.19 1.54 0–9.80 0.53 0.79 2,988 821
Cognitive disorganization 3.83 2.82 0–11.00 0.51 0.77 2,987 823
Parent-rated negative symptoms 0.88 1.19 0–9.33 2.35 0.84 2,995 833
ALSPAC
Paranoia and hallucinations 0.27 0.51 0–4.17 2.78 0.67 3,591 0
Anhedonia 1.42 1.19 0–7.00 1.09 0.73 3,591 0
Parent-rated negative symptoms 1.57 1.11 0–7.00 0.61 0.61 4,019 0
CATSS
Paranoia and hallucinations 0.20 0.43 0–5.00 3.92 0.73 2,080 849
Cognitive disorganization 1.95 0.98 0–5.00 0.35 0.79 3,310 1,335
Parent-rated negative symptoms 0.57 0.95 0–8.50 2.64 0.75 3,084 1,395
Note. These figures are based on the individuals remaining after quality control and were used in all subsequent genetic analyses. ALSPAC5Avon
Longitudinal Study of Parents and Children; CATSS5Child and Adolescent Twin Study in Sweden; TEDS5Twins Early Development Study.
aMean.
bStandard deviation.
cStandardized Cronbach’s alpha.
dNumber of genotyped individuals after exclusions.
eNumber of siblings pairs within N.
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across (mega-) samples. The effective sample size was used in LD-score
regression analyses, thus matching the sample in the GWAS. Effective
sample size was calculated as follows: (2*sample size)/(11 correlation
between siblings) (Minica, Boomsma, Vink, Dolan, 2014). There was no
evidence of confounding from genome-wide association results so the
intercept was constrained to 1.
2.6 | Mega-GWAS
The three samples were combined to enable genome-wide association
mega-analysis. Genome-wide association analysis of all four psychotic-
like experience domains using related (i.e. monozygotic and dizygotic
twin pairs) and unrelated individuals was performed in PLINK (http://
pngu.mgh.harvard.edu/purcell/plink/) (Purcell et al., 2007). Additional
covariance arises from related individuals; this was accounted for using
the method of generalizable estimating equations (GEEs) (Minica et al.,
2014; Minica, Dolan, Kampert, Boomsma, & Vink, 2015) in R specifying
an exchangeable correlation matrix.
2.7 | Replication analysis of rs149957215 association
with Anhedonia
After the discovery sample had been prepared and analyzed for this
project, an independent subsample of TEDS participants was geno-
typed. Of the newly genotyped individuals, 2,359 (incl. 635 MZ pairs)
had reported on self-rated Anhedonia. This independent TEDS sample
was used as a replication sample for the validation of the genome-wide
significant association between rs149957215 and Anhedonia identified
by the mega-GWAS in this study. rs149957215 genotypes were
imputed (MACH r250.93) using the haplotype reference consortium
data via the Sanger imputation server (McCarthy et al., 2016). The gen-
otypic data was converted to hard-call format (certainty threshold of
0.9) and analyzed in PLINK using the same GEE method to account for
relatives. This replication analysis had a power of 0.86 to detect an
association of the same magnitude (r250.47%) at nominal significance.
2.8 | Gene-based association analysis
Two gene-based association analyses were performed. The first aggre-
gates SNP associations within specific gene regions using the MAGMA
program (de Leeuw, Mooij, Heskes, & Posthuma, 2015). The second
analysis used PrediXcan (Gamazon et al., 2015) to predict frontal cortex
gene expression differences using genotypic data. Further details can
be found in Supporting Information Note S5.
2.9 | Genetic association between psychotic-like
experience domains and psychiatric disorders
Using the software PRSice (Euesden, Lewis, & O’Reilly, 2015), poly-
genic risk scores (PRSs) of schizophrenia, bipolar disorder, and major
depression were calculated in the adolescent sample using the log of
the odds ratios from the latest Psychiatric Genomics Consortium
GWAS of schizophrenia (PGC2) (Ripke et al., 2014), bipolar disorder
(PGC Bipolar Disorder Working Group, 2011), and major depression
(Ripke et al., 2013). LD was controlled for using LD-based clumping
with an r2-cutoff of 0.1 within a 250-kb window. For each individual,
scores were generated using SNPs with the following p-value thresh-
olds (pT): 0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5. Linear regressions
were performed in R and GEE was used to account for related individu-
als. Quantile plots were created to further examine the relationships. If
there was evidence of a non-linear relationship from the quantile plots,
the non-linear relationship was formalized by performing linear regres-
sion in a subset of individuals.
To estimate the genetic covariance between psychotic-like experi-
ence domains and schizophrenia, bipolar disorder, and major depres-
sion, both LD-score regression and additive variance explained and
number of genetic effects method of estimation (AVENGEME) were
used (Bulik-Sullivan et al., 2015; Palla & Dudbridge, 2015). AVENGEME
uses the results of PRS analyses across multiple significance thresholds
to estimate the model parameters including the genetic covariance.
AVENGEME estimates 95% confidence intervals using profile likeli-
hood method. There was no evidence of confounding or sample over-
lap in the mega-GWAS summary statistics, as such the heritability-
intercept was constrained to 1 and the genetic covariance intercept
was set to 0 in LD-score regression. To improve the accuracy of the
estimates of genetic covariance derived from the AVENGEME analysis,
the SNP-heritability of liability for schizophrenia, bipolar disorder, and
major depression were constrained to the LD-score regression esti-
mates of SNP-heritability (see Supporting Information Table S8).
3 | RESULTS
Table 1 shows the descriptive statistics of psychotic-like experience
domains split by sample. The relationship between each psychotic-like
TABLE 2 SNP-heritability estimates for psychotic-like experience domains
Meta-GREML Meta-LDSC
Specific PE SNP-h2a SE p SNP-h2a SE p
Paranoia and hallucinations 0.028 0.050 .293 0.066 0.068 .168
Anhedonia 0.088 0.055 .057 0.204 0.078 4.513 1023
Cognitive disorganization 0.059 0.063 .176 0.215 0.085 5.793 1023
Parent-rated negative symptoms 0.059 0.045 .096 0.119 0.061 .026
aPhenotypic variance explained by tagged common genetic variation.
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experience domain with age and sex are available in Supporting Infor-
mation Tables S9 and S10. After phenotypic harmonization and quality
control, the final sample sizes (including siblings) for all subsequent
analyses were 8,665 for Paranoia and Hallucinations, 6,579 for
Anhedonia, 6,297 for Cognitive Disorganization, and 10,098 for
Parent-rated Negative Symptoms.
SNP-heritability estimates from meta-GREML and meta-LD-score
regression were between 2.8–8.8% and 6.6–21.5%, respectively
(Table 2). Results from secondary analysis of SNP-heritability using the
mega-analysis approach are given in Supporting Information Table S11.
The mega-GWAS identified no genome-wide significant variation
for the Paranoia and Hallucinations, Cognitive Disorganization, or
Parent-rated Negative Symptoms domains. The mega-GWAS of
Anhedonia identified one SNP (rs149957215) associated at genome-
wide significance (p53.76 3 1028) within a gene called indoleamine
2,3-dioxygenase 2 (IDO2) (Supporting Information Figure S1). This SNP
was imputed in both samples included in the Anhedonia GWAS (TEDS
and ALSPAC) with an average imputation quality (INFO) of 0.87 and
minor allele frequency of 0.015. The minor allele frequency was similar
in both TEDS (0.017) and ALSPAC (0.013). Due to limited LD with
rs149957215, neighboring genetic variation showed no significant
evidence of association. This association between rs149957215 and
Anhedonia did not replicate in the independent TEDS replication sam-
ple, showing a non-significant association (p50.81) in the opposite
direction. Several loci achieved suggestive significance (p<1 3 1025)
across the four psychotic-like experience domains (Supporting Informa-
tion Table S12 and Figures S2–S5). There was no evidence of con-
founding with lambdas of 0.99–1.01 and LD-score regression intercept
of 1.00 in all analyses (Supporting Information Figure S6).
Regional gene-based tests identified no gene that was significantly
associated with any psychotic-like experience domain after Bonferroni
correction for multiple testing. The top ten most associated genes for
TABLE 3 Schizophrenia, bipolar disorder, and major depression polygenic risk scores predicting psychotic-like experience domains in
adolescents
Specific PE b SE P r2 (%) pTa
Schizophrenia
Paranoia and hallucinations 20.005 0.011 .664 0.002 0.200
Paranoia and hallucinations excl. zero scorers 0.031 0.012 7.9031023 0.094 0.001
Anhedonia 0.028 0.013 .030 0.079 0.100
Cognitive disorganization 0.029 0.014 .035 0.083 0.010
Parent-rated negative symptoms 0.030 0.011 5.4131023 0.088 0.050
Bipolar disorder
Paranoia and hallucinations 20.034 0.011 2.4731023 0.115 0.010
Anhedonia 20.017 0.013 .178 0.030 0.100
Cognitive disorganization 20.013 0.014 .333 0.017 0.001
Parent-rated negative symptoms 20.009 0.011 .388 0.008 0.500
Major depression
Paranoia and hallucinations 0.006 0.011 .589 0.004 0.100
Anhedonia 0.033 0.013 .010 0.109 0.500
Cognitive disorganization 0.018 0.014 .189 0.033 0.050
Parent-rated negative symptoms 0.028 0.011 8.2931023 0.078 0.001
This table shows results for polygenic risk scores at the most predictive p-value threshold for each trait.
Statistically significant results are highlighted in bold.
ap-value threshold used to select when calculating polygenic risk scores.
FIGURE 1 Polygenic risk scores for schizophrenia, bipolar disorder, and major depression predict adolescent psychotic-like experience
domains. This figure shows results for polygenic risk scores at the most predictive p-value threshold for each trait. Error bars are 95%
confidence intervals (95% CI) [Color figure can be viewed at wileyonlinelibrary.com]
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each psychotic-like experience domain are listed in Supporting Informa-
tion Table S13.
Analysis of predicted frontal cortex gene expression associated
with psychotic-like experience domains showed HACD2 as significantly
differentially expressed for Cognitive Disorganization (Bonferroni
corrected p56.83 3 1024). The top ten genes showing differential
expression for each psychotic-like experience domain are listed in
Supporting Information Table S14.
The schizophrenia PRS significantly and positively predicted
Anhedonia (p5 .030 at pT50.10), Cognitive Disorganization
(p5 .035 at pT50.01) and Parent-rated Negative Symptoms
(p55.41 3 1023 at pT50.05) (Table 3; Figure 1). The bipolar
disorder PRS significantly and negatively predicted Paranoia and Hal-
lucinations only (p52.47 3 1023 at pT50.010) (Table 3; Figure 1).
The major depression PRS significantly and positively predicted Anhe-
donia (p5 .010 at pT 0.5) and Parent-rated Negative Symptoms
(p58.29 3 1023 at pT50.001) (Table 3; Figure 1). Supporting Infor-
mation Tables S15–S17 and Figures S7–S9 show the full results of
these analyses. Logistic regression comparing PRSs in low and high
psychotic-like experience domain groups (defined as bottom and top
25% of raw psychotic-like experience sum scores) were congruent
with linear analyses (Supporting Information Table S18 and
Figure S10).
Quantile plots showing the mean PRS within subsets of the
psychotic-like experience distributions highlighted one non-linear rela-
tionship between the schizophrenia PRS and Paranoia and Hallucina-
tions, with the point of inflection at the median (Supporting
Information Figure S11). The majority of individuals (81%) below the
median had a raw score of zero. A single post-hoc analysis was
performed to formalize the presence of this non-linear relationship.
Post-hoc removal of individuals with a raw Paranoia and Hallucinations
score of zero led to the schizophrenia PRS positively predicting
Paranoia and Hallucinations (p57.90 3 1023 at pT50.001) (Table 3;
Figure 1; Supporting Information Table S15). Logistic regression com-
paring low and high groups of non-zero scoring individuals supported
these findings (Supporting Information Table S18 and Figure S10).
Table 4 presents the AVENGEME estimates of genetic covariance,
which were highly congruent with the PRS analysis results. AVEN-
GEME pools evidence across p-value thresholds tested from PRS analy-
sis. As such, even when there is consistent but non-significant
evidence of association at individual p-value thresholds, AVENGEME
genetic covariance estimates can be significant. Consequently, there
were two significant results that were not shown by the PRS analyses;
between the Anhedonia psychotic-like experience domain and bipolar
disorder (genetic covariance520.022, 95% CI520.041 to 20.002),
and the Cognitive Disorganization psychotic-like experience domain
and major depression (genetic covariance50.033, 95% CI50.005–
0.062).
Table 4 presents estimates of genetic covariance from LD-score
regression. LD-score regression mirrored over half of the significant
associations shown between the equivalent PRSs and psychotic-like
experience domains in Table 3. The genetic covariance between the
schizophrenia PRS and non-zero scorers on Paranoia and Hallucinations
could not be estimated because the genome-wide association analysis
included zero scorers. Unlike for the equivalent results in Table 3, the
genetic covariance between schizophrenia and anhedonia psychotic-
like experience domain, and between major depression and parent-
rated negative symptoms domain, were not significant.
4 | DISCUSSION
A genetic relationship was identified between clinical schizophrenia
and positive, cognitive, and negative psychotic-like experience trait
domains in adolescence. A higher genetic risk for schizophrenia
TABLE 4 Genetic covariance between each psychotic-like experience domain and schizophrenia, bipolar disorder, and major depression
AVENGEME LDSC
Specific PE cov(G)a Low 95% CI High 95% CI cov(G)a SE p
Schizophrenia
Paranoia and hallucinations 20.002 20.013 0.008 20.003 0.014 .844
Paranoia and hallucinations excl. zero scorers 0.019 0.011 0.029 NA NA NA
Anhedonia 0.024 0.013 0.038 0.021 0.016 .184
Cognitive disorganization 0.025 0.013 0.040 0.054 0.018 3.523 1023
Parent-rated negative symptoms 0.025 0.015 0.036 0.047 0.014 5.573 1024
Bipolar disorder
Paranoia and hallucinations 20.032 20.048 20.018 20.045 0.022 .039
Anhedonia 20.022 20.041 20.002 0.008 0.028 .767
Cognitive disorganization 0.008 20.013 0.029 0.021 0.028 .451
Parent-rated negative symptoms 20.010 20.026 0.006 0.009 0.021 .669
Major depressive disorder
Paranoia and hallucinations 0.004 20.018 0.026 0.013 0.020 .523
Anhedonia 0.065 0.037 0.094 0.061 0.023 7.503 1023
Cognitive disorganization 0.033 0.005 0.062 0.015 0.028 .594
Parent-rated negative symptoms 0.023 0.010 0.042 0.031 0.020 .119
Statistically significant results are highlighted in bold.
aGenetic covariance.
6 | PAIN ET AL.
significantly predicted adolescents having more cognitive disorganiza-
tion, anhedonia, and parent-rated negative symptoms, as well as more
paranoia and hallucinations (this last finding was in the non-zero scor-
ers). Thus our findings suggest that psychotic-like experience trait
domains in adolescence comprise partly of the genetically-influenced
phenotypic manifestation of schizophrenia. Furthermore, higher genetic
risk for major depression significantly predicted having more self-rated
anhedonia and parent-rated negative symptoms as a teenager. Our
results discredit the hypothesis that psychotic-like experience trait
domains in the general population are epiphenomena that do not share
biological pathways with clinically-recognized psychiatric disorders.
Genetic risk for schizophrenia and major depression in adulthood
predicted 0.08–0.11% variance in psychotic-like experience domains in
adolescence. The effect sizes are likelydownward biased because of
the conservative approaches taken here to align different samples and
to handle skewed variables. Nevertheless, comparable effect sizes have
been reported in equivalent studies on other phenotypes, for example,
linking social communication traits to genetic liability for autism (St
Pourcain et al., 2017). Large effect sizes were not expected. The upper
limit of prediction is the degree to which PRSs for schizophrenia and
major depression predict themselves (that is, their own phenotype) in
an independent sample, which is 18.4% for schizophrenia (Ripke
et al., 2014) and 0.6% for major depression (Ripke et al., 2013). It is
known from epidemiological studies that the magnitude of phenotypic
association between psychotic-like experience domains and schizo-
phrenia is modest (McGrath et al., 2016; Zammit et al., 2013) and far
more people report psychotic-like experiences in adolescence than
develop disorders such as schizophrenia. Furthermore, there is consid-
erable heterogeneity in schizophrenia and depression in terms of age
of onset and symptom presentation. The associations were likely to be
modest given their cross-phenotype and cross-age nature. The genetic
association between psychiatric disorders and psychotic-like experi-
ence traits in the community may increase with age or with longitudinal
assessments.
A notable result was that paranoia and hallucinations during adoles-
cence are associated with schizophrenia common genetic risk if individu-
als report at least some degree of paranoia or hallucinations, that is, the
association was only present in the non-zero scorers. Individuals report-
ing no paranoia and hallucinations can exist anywhere on the schizo-
phrenia genetic liability spectrum. Previous studies did not find a genetic
association between schizophrenia and positive psychotic-like experien-
ces (Jones et al., 2016; Sieradzka et al., 2014; Zammit et al., 2014). The
use of quantitative traits and a large sample allowed the identification of
this non-linear effect here. An explanation for the non-linear effect may
lie in the variable age of onset of paranoia and hallucinations. Our study
was focused on psychotic-like experiences in mid to late adolescence. It
is predicted that stronger positive associations between genetic risk for
schizophrenia and positive psychotic-like experiences will be found in
samples assessed over a longer time frame, when anyone who is going
to have paranoia and hallucinations has manifested them.
The significant and positive genetic association between a self-
rated anhedonia trait measure in adolescence and major depression in
adulthood concurs with a previous report showing that subclinical
depressive symptoms (including anhedonia) phenotypically predict
major depressive episodes in adulthood (Pine, Cohen, Cohen, & Brook,
1999). Anhedonia is present as a symptom of both schizophrenia and
depression in psychiatric diagnoses, and our research shows that as a
trait dimension in adolescence it shares common genetic underpinnings
with both schizophrenia and depression.
The significant negative association between paranoia and halluci-
nations and bipolar disorder genetic risk also deserves discussion.
Previous research reported the presence of paranoia, hallucinations,
and delusions prior to the onset of bipolar disorder (McGrath et al.,
2016). However, our results suggest that genetic influences on para-
noia and hallucinations as traits during mid-adolescence are negatively
associated with known common genetic risk associated with diagnosed
bipolar disorder. The common genetic relationship between adolescent
paranoia and hallucinations and bipolar disorder requires replication in
an independent sample. Further insight into this relationship will also
be gained as more powerful polygenic predictors for bipolar disorder
become available.
Although in many cases the SNP-heritability estimates were not
significantly non-zero, the point estimates of SNP-heritability indicate
that common genetic variation influences psychotic-like experience
domains during adolescence. This concurs with results from twin stud-
ies reporting significant twin heritability estimates (Zavos et al., 2014).
The SNP that achieved genome-wide significance in the mega-
GWAS for anhedonia lies within the protein-coding gene IDO2. IDO2
is a key enzyme in the regulation of the kynurenine pathway, which
upon stimulation by proinflammatory cytokines, converts tryptophan
into kynurenine. It has been reported that increased metabolism of
tryptophan to kynurenine is associated with increased depressive
symptoms via the increased production of cytotoxic kynurenine metab-
olites (Dantzer, O’Connor, Lawson, & Kelley, 2011; Myint et al., 2007;
Wichers et al., 2005). In fact, a previous study has reported a significant
correlation between kynurenine production and anhedonia in an
adolescent sample (Gabbay, Ely, Babb, & Liebes, 2012). These previous
studies suggest the association between IDO2 and anhedonia is plausi-
ble. However, this association should be interpreted with caution as
rs149957215 was imputed in all three samples, has a low minor allele
frequency of 0.013, and appears to be uncorrelated with surrounding
common genetic variation. Furthermore, this association failed to repli-
cate in a sufficiently powered independent sample.
Some methodological details deserve consideration. A key strength
of the study is the derivation of psychometrically-sound quantitative
individual psychotic-like experience domains: These were derived using
principal component analysis and have content validity. It is noted that
our terminology of psychotic-like experiences, like others (Alemany
et al., 2013; Stefanis et al., 2002; Wigman et al., 2011), includes posi-
tive, cognitive, and negative psychotic-like experiences, for the reason
that at the extreme these experiences are characteristic of clinical psy-
chotic disorders. Greater power was achieved compared to past
research through combining independent samples. At the same time,
slight variations in measure items across samples impacts the amount
of phenotypic variance that can be explained by common genetic varia-
tion. The correlation between specific psychotic-like experiences were
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typically consistent within each sample, however the relationship
between Paranoia and Hallucinations and other psychotic-like experi-
ences did vary to some degree (Supporting Information Table S6). For
the more skewed psychotic-like experience domains with larger num-
bers of tied individuals, the process of randomly ranking tied individuals
during normalization was essential but will have introduced noise and
thus downward biased SNP-heritability estimates. This study used
multiple PRS selection thresholds (referred to as pTs), however the
p-values for each selection threshold result have not been corrected
for multiple testing. Due to the high correlation between PRS selection
thresholds, even when considering all possible selection thresholds, it
has been estimated that a significance threshold of p5 .001 is appro-
priate (Euesden et al., 2015). This threshold would be overly conserva-
tive in our study as we only tested a limited number of thresholds.
Genetic covariance estimates obtained by AVENGEME (Table 4) take
all selection thresholds into account simultaneously, and therefore
need no adjustment for multiple testing. We note that the significance
of the PRS associations is supported by the confidence intervals of the
AVENEMGE genetic covariance estimates. This study has identified
significant common genetic covariance between several psychotic-
like experiences and psychiatric disorders. It remains possible that
the genetic covariance estimates could be partly explained by the pres-
ence of adolescents with diagnosed relatives. If an adolescent has a rel-
ative with schizophrenia for example, the adolescent may have
increased psychotic-like experiences due to their shared environment
with the relative. However, twin and adoption studies of schizophrenia
and psychotic-like experiences do not support this mode of transmis-
sion. Finally, each psychotic-like experience domain was viewed as a
single phenotype of interest in its own right. As such, this study was
treated as a series of self-contained individual trait studies, rather than
as a single exploratory study across traits. Therefore we did not
formally correct for multiple testing of traits, similar to other studies of
this nature (Cross-Disorder Group of the Psychiatric Genomics Consor-
tium, 2013; Wellcome Trust Case Control Consortium, 2007). Note
however that nearly all of our associations would remain significant
after correction for testing four PE domains, while the association of
rs149957215 with Anhedonia (p53.7631028) did not replicate.
Collectively, these findings reveal novel evidence for some shared
common genetic etiology between psychotic-like experience domains
in mid to late adolescence and clinically-recognized psychiatric disor-
ders in adulthood. Evidence is accruing that psychotic-like experiences
manifested prior to adulthood form part of a wider phenotype or pro-
drome related to psychiatric disorders such as schizophrenia and
depression. This study joins the existing evidence that individuals with
a family history of schizophrenia score higher on psychotic-like experi-
ence scales (Jeppesen et al., 2014; Zavos et al., 2014), psychotic-like
experiences are associated with the same environmental risk factors as
schizophrenia (Linscott & Van Os, 2013), psychotic-like experiences are
on a phenotypic and etiological continuum across the severity contin-
uum (Taylor et al., 2016; Zavos et al., 2014), and psychotic-like experi-
ences predict later psychiatric disorders (Cederl€of et al., 2016; Fisher
et al., 2013; Kelleher, Cederl€of, & Lichtenstein, 2014; Kelleher et al.,
2012; Werbeloff et al., 2012; McGrath et al., 2016; Zammit et al.,
2013). The next step is to consider how psychotic-like experiences can
be harnessed in a practical sense as a (small effect size) red flag for risk
in early intervention and prevention strategies. Similar to family history,
psychotic-like experiences might be a useful heuristic even if the major-
ity of individuals with psychotic-like experiences will remain unaffected
by psychiatric disorders.
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